SERPINA3 and type 2 diabetes mellitus: The present study confirmed the upregulation of SERPINA3 in DCI samples, which corresponds to the combined state of elevated systemic inflammatory levels, increased insulin resistance, and impaired cerebral microvascular function in patients with type 2 diabetes mellitus.